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Available online 9 March 2016The imprinted genes of primate embryonic stem cells (ESCs) often show altered DNAmethylation. It is unknown
whether these alterations emerge while deriving the ESCs. Here we studied the methylation patterns of two dif-
ferentially methylated regions (DMRs), SNRPN and H19/IGF2 DMRs, during the derivation of monkey ESCs. We
show that the SNRPNDMR is characteristicallymethylated atmaternal alleles, whereas theH19/IGF2DMR is glob-
ally highlymethylated,with unusualmethylation on thematernal alleles. Thesemethylation patterns remain sta-
ble from the early stages of ESC derivation to late passages of monkey ESCs and following differentiation.
Importantly, the methylation status of H19/IGF2 DMR and the expression levels of IGF2, H19, and DNMT3B
mRNAs in early embryo-derived cells were correlated with their capacity to generate genuine ESC lines. Thus,
we propose that these markers could be useful to predict the outcomes of establishing an ESC line in primates.
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Genomic imprinting is an epigenetic mechanism that ensures the
differential expression of imprinted genes in a parent-of-origin fashion.
The alleles of imprinted genes are marked with their parental origin by
DNA methylation at differentially methylated regions (DMRs), which
are CpG-rich-cis-elements within the locus (Reik and Walter, 2001).
In order to be inherited fromone generation to the next, these epigenet-
ic marks are erased early in life in primordial germ cells and reset in the
germline as per sex (Hajkova et al., 2002). The altered methylation of
imprinted genes leads to improper gene dosage during embryonic de-
velopment and has been associated with several pathologies, including
cancers andneurological disorders (Reed and Leff, 1994; Orstavik, 1999;
Feinberg, 2004; Demars andGicquel, 2012; Brioude et al., 2013;McCann
et al., 1996; Takai et al., 2001). Recent studies have suggested that
assisted reproductive technologies (ARTs), such as superovulation,
in vitro fertilisation and embryo culture, favour acquisition of imprinting
errors, which can lead to diseases and developmental defects (DeBaunntially methylated region; IGF,
).
. This is an open access article underet al., 2003; Gicquel et al., 2003; Maher et al., 2003; Orstavik et al.,
2003; Borghol et al., 2006; Bowdin et al., 2007; Khoueiry et al., 2008;
Grace and Sinclair, 2009; Chen et al., 2010; Ibala-Romdhane et al.,
2011; Khoueiry et al., 2013). During the early stages of embryonic
stem cells (ESCs) isolation from pre-implantation stage embryos, em-
bryonic cells are subject to intense in vitromanipulation and environ-
mental changes that may impact the epigenetic status and irreversibly
alter the capacity to generate ESC lines or to exhibit the full differentia-
tion potential of genuine ESCs. Primate ESCs often show altered DNA
methylation on imprinted genes, particularly imprinted genes, such as
H19/insulin-like growth factor2 (IGF2) (Fujimoto et al., 2006; Mitalipov,
2006; Mitalipov et al., 2007; Frost et al., 2011). However, it is unknown
whether these alterations emerge during ESC isolation and whether
they are correlated with the ESC outcome. To address these questions,
we analysed the methylation proﬁles of two well-characterised DMRs,
H19/IGF2 and SNRPN DMRs, while deriving monkey ESCs. The H19/
IGF2 DMR is the best candidate for this study because its methylation
status is particularly sensitive to changes in culture conditions and dif-
ferentiation (Sasaki et al., 1995; Doherty et al., 2000; Khosla et al.,
2001; Mann et al., 2004). The H19/IGF2 DMR acquires methylation in
the paternal germline and is characteristically unmethylated on mater-
nal alleles. TheH19/IGF2DMR regulates the expression of two opposite-
ly imprinted genes, such as IGF2 and H19. The IGF2 locus encodes IGF2,
an autocrine/paracrine mitogen, and transcription of H19 produces athe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
558 F. Wianny et al. / Stem Cell Research 16 (2016) 557–567non-coding RNA, which is a precursor of a microRNA called miR-675
that negatively affects cell proliferation (Keniry et al., 2012).
Hyper-methylation of this DMR can result in IGF2 overexpression
and is linked to an increased frequency of Beckwith–Wiedemann
syndrome (DeBaun et al., 2003; Weksberg et al., 2003), whereas
hypo-methylation of the paternal allele is associated with the
Silver–Russell syndrome, which is characterised by slow growth be-
fore and after birth (Gicquel et al., 2005). In contrast to the H19/IGF2
DMR, the SNRPN DMR is methylated on the maternal allele and
unmethylated on the paternal allele. In humans, it is located on chro-
mosome 15q11–13, which is a region involved in Prader–Willi and
Angelman syndromes (AS) (Reed and Leff, 1994; Leff et al., 1992;
Buiting et al., 1995). Methylation of this DMR is not sensitive to envi-
ronmental alterations, including the in vitro manipulation of mouse
ESCs (Schumacher and Doerﬂer, 2004), which makes it a good mark-
er of methylation stability.
Here, we demonstrate that themethylation patterns of theH19/IGF2
and SNRPN DMRs were stable from the early stages of derivation to late
passages of monkey ESCs, and following in vitro differentiation.We also
showed that the H19/IGF2 DMR methylation pattern was correlated
with the capacity of early embryo-derived cell lines to generate a bona
ﬁde ESC line.Fig. 1. Methylation status of the SNRPN differentiallymethylated region (DMR) in LYON-ES1
theMacaca mulatta SNRPNDMR. A 323 bp fragment of the SNRPNDMR (126678–127001, NC_0
shown. B. Left panel, bisulphite-sequencing analysis of the SNRPNDMR in LYON-ES1 cells at pas
allele. Black squares indicate methylated CpGs.White squares indicate unmethylated CpGs. Red
maternal and paternal alleles of LYON-ES1 cells at passages 7 and 50 and after differentiation int
was used to compute allele methylation status (ns, p N 0.05). DIF, differentiation; EB, embryoid2. Results
2.1. The SNRPN and H19/IGF2 DMR methylation patterns in the rhesus
monkey ESC lines
First, we studied the epigenetic status of the rhesus monkey LYON-
ES1 line (Wianny et al., 2008) duringderivation and after long-term cul-
ture. We analysedH19/IGF2 and SNRPNDMRmethylation status using a
sensitive bisulphite sequencing technique that previously enabled to
perform a methylation analysis on single oocytes and early human em-
bryos (Khoueiry et al., 2008; Lefevre and Blachere, 2015). Identiﬁcation
of single nucleotide polymorphisms (SNPs) within each DMR enabled
allele-speciﬁc methylation analyses of parentally imprinted DMRs. The
SNRPN DMR is classically methylated on the maternal allele and
unmethylated on the paternal allele (Reed and Leff, 1994). We deﬁned
a SNP within the SNRPN DMR (a C/G polymorphism at position
126776; NC_007864.1) of the rhesus monkey genome to analyse the
levels of SNRPN DMR methylation on the paternal and maternal alleles
(Fig. 1A). We analysed 26 CpG sites within the DMR of each allele. At
early stage of LYON-ES1 cell derivation (passage 7), the SNRPN DMR
was differentially methylated, with a high level of methylation on the
maternal allele (91.6%) and a low level of methylation on the paternalcells at early and late passages and after differentiation.A. Schematic representation of
07864.1) harbouring a single nucleotide polymorphism (SNP) G/C at nucleotide 126776 is
sages 7 and 50 and in EBs after 14 days of suspension culture. Each line represents a single
squares indicate the SNP. Right panel, percentage of methylation of the SNRPNDMR in the
o EBs andNP after 40days in culture.Mean± standard error of themean. Fisher's exact test
bodies; NP, neural precursors; ns, not signiﬁcant.
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methylation pattern at passage 50 (91.3% and 3.6% on the maternal and
paternal alleles, respectively) (Fig. 1B), indicating that this pattern is
stable over time in culture. Similar results were obtained for ORMES-1
and ORMES-6, two other rhesus ESC lines (Supplementary Fig. 1A).
These results agree with published data for other monkey ESC lines
(Mitalipov et al., 2007).
The H19/IGF2 DMR is classically methylated on the paternal allele
and unmethylated on the maternal allele (Zhang et al., 1993). We de-
ﬁned T/A at position 252 as an SNP in the CTCF-binding site of the
H19/IGF2DMR (AY725988.1) to distinguish the parental origin of the al-
leles (Fig. 2A). At early stage of LYON-ES1 cell derivation (passage 7),
the H19/IGF2 DMR was highly methylated on the paternal allele (84%).
In contrast, abnormal H19/IGF2 DMRmethylation was observed on the
maternal allele (34%; Fig. 2B). The LYON-ES1 cells exhibited similarFig. 2.Methylation status of theH19/IGF2differentiallymethylated region (DMR) in LYON-E
of theMacaca mulatta H19/IGF2 DMR. A 434 bp fragment of the H19 DMR in the CTCF-binding
nucleotide 249 is shown. B. Left panel, bisulphite-sequencing analysis of the H19/IGF2 DMR i
(P5). Twenty to 40 clones were sequenced from each sample. Right panel, percentage methyl
7, 33 and 50 and after differentiation into EBs and NP after 40 days in culture. Mean ± stand
(ns, p N 0.05). DIF, differentiation; EB, embryoid bodies; NP, neural precursors; ns, not signiﬁcaaltered methylation pattern of H19/IGF2 DMR at passages 33 and 50
(75% for the paternal allele; 28% and 24% for the maternal allele at pas-
sages 33 and 50, respectively) (Fig. 2B). Similar results were obtained
for ORMES-1 and ORMES-6 cells, as well as for the human ESC line H9
(Supplementary Fig. 1B). Thus, the SNRPN and H19/IGF2 DMRmethyla-
tion patterns observed at the early stages of LYON-ES1 cell derivation
were preserved during subsequent passages.
Next, we examined the SNRPN and H19/IGF2 DMR methylation
status during differentiation induced by growing monkey ESCs in sus-
pension to generate embryoid bodies (EBs), which contain cells of the
three germ lineages (Sasaki et al., 2005; Wianny et al., 2008). On day
14 of differentiation, the SNRPN DMR was still poorly methylated on
the paternal allele (7.2%) but highly methylated on the maternal allele
(82.7%) (Fig. 1B). The H19/IGF2 DMR was highly methylated (66.2%)
on the paternal allele and abnormally methylated (36.2%) on theS1 cells at early and late passages and after differentiation.A. Schematic representation
site (222–656; AY725988.1) harbouring a single nucleotide polymorphism (SNP) T/A at
n LYON-ES1 cells at passages 7, 33 and 50 and in EBs after 14 days of suspension culture
ation of the H19/IGF2 DMR in maternal and paternal alleles of LYON-ES1 cells at passages
ard error of the mean. Fisher's exact test was used to compute allele methylation status
nt.
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IGF2 DMR methylation patterns as those of undifferentiated LYON-ES1
cells. Similarly, neural derivatives of LYON-ES1 cells propagated for
40 days exhibited SNRPN and H19/IGF2 DMR methylation patterns
similar to those described for undifferentiated LYON-ES1 cells (Figs. 1B
and 2B).
Taken together, these results indicate that the LYON-ES1 cell line, ex-
hibits a differential SNRPN DMRmethylation pattern and aberrant H19/
IGF2 DMR methylation on the maternal allele, as observed in other pri-
mate ESC lines (Mitalipov et al., 2007; Nazor et al., 2012). They also sug-
gest that these methylation patterns are highly stable during long-term
self-renewal and differentiation.Fig. 3. Derivation of pre-ESC lines from early rhesus embryos. A. Box-and-whiskers plot rep
LYON-ES1 and the pre-ESC lines until passage 8. B. Growth rate of the pre-ESC lines and LYON
Data form the literature showing the growth rate of human and monkey ESC lines during the
lines according to the maximum number of passage reached in vitro. The LYON-ES1 cell line i
LYON-ES1 cell line. Scale bars, 100 μm.2.2. SNRPN and H19/IGF2 DMR methylation patterns in pre-ESC lines
We generated 166 fertilised rhesus embryos following intracellular
sperm injection (ICSI), of which thirty-four were developed to the blas-
tocyst stage. Thirty embryos or inner cell masses (ICMs) attached to
feeder cells, ofwhich 15 produced an outgrowth that could be expanded
for more than ﬁve passages. They include the LYON-ES1 cell line de-
scribed above, and 14 lines, designated 19–33 (Sup. Table 1), that failed
to expand beyond passage 20 and aborted during subsequent passages.
These 14 lines are referred to as the pre-ESC lines.
LYON-ES1 cells showed a high proliferation rate (5.9 ± 0.9 days
between two successive passages), similar to other monkey ESCsresentations of passage frequency (mean duration between two successive passages) for
-ES1 cell line until passage 11. Each line is represented with the same colour than in A. C.
ﬁrst ﬁve passages (compared to pre-ESC lines). D.Morphology and numbering of the cell
s indicated in red. The pre-ESC lines nb. 24 and 28 showed similar morphology to that of
Fig. 4. Characterisation of the pre-ESC lines. A. Immunoﬂuorescent staining for the SSEA4 and TRA-1-81 or TRA-1-60 surface antigens in rhesus monkey ESCs (LYON-ES1 and ORMES-1
lines) and the pre-ESC lines nb. 20, 21, 22, 24, 28, 31, 32 and 33. Nuclei were counterstained with Hoechst 33258 (blue). Scale bar, 100 μm. B. Levels of SOX2, NANOG, OCT4 (left), FGF5,
LEFTY1 SOX17, GATA6 and T-BRAmRNAs measured by qPCR in the pre-ESC lines and LYON-ES (mean ± standard error of the mean calculated from three replicates after normalisation
to PGK1). C. mRNA expression of the SOX1, AFP, HNF-3β, α-MHC differentiation markers measured by RT-PCR in the pre-ESC and LYON-ES1 cell lines (ES). D.Morphology of the EBs
after 14 and 4 days of culture of pre-ESC lines 31, 32 and 33, LYON-ES1 and ORMES-6 cells. Scale bar, 200 μm. E. Teratoma formation 14 weeks after injecting pre-ESC lines 31 and 32
and 5 weeks after injecting LYON-ES1 cells in the testis of SCID mice. Two mice for each cell line were studied and produced similar results. AFP, alpha feto protein; FGF, ﬁbroblast
growth factor; HNF, hepatocyte nuclear factor; MHC, myosin heavy chain; wks, weeks.
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and B). In contrast, the pre-ESC lines exhibited a slower growth rate
than other monkey and human ESC lines at early stages of derivation
(Thomson et al., 1998; Mitalipova et al., 2003; Pickering et al., 2003;
Inzunza et al., 2005; Baharvand et al., 2006; Mitalipov et al., 2006;
O'Leary et al., 2013) (Fig. 3B and C), resulting in culture durations of
7.6–16 days between two successive passages (passage 10was reached
after 83–102 days, depending on the pre-ESC line). Most of the pre-ESClines grew as three-dimensional compact colonies with poorly visible
nuclei (Fig. 3D). Only two (lines 24 and 28) cell lines displayed typical
monkey ESC morphology with a high nuclear/cytoplasmic ratio. No
morphological changes were observed after long-term culture of these
two lines (data not shown). Eight pre-ESC lines (Khoueiry et al., 2013;
Fujimoto et al., 2006; Mitalipov, 2006; Frost et al., 2011; Mann et al.,
2004) were expanded and analysed for the expression of cell surface
markers. All of them expressed the SSEA4, TRA-1-60 and/or TRA-1-81
562 F. Wianny et al. / Stem Cell Research 16 (2016) 557–567
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itive for alkaline phosphatase (Supplementary Fig. 2). Extensive gene
expression analysis of these slow growing pre-ESCs could not be per-
formed; we thus analysed several pluripotent and differentiation
markers using RT-PCR. We observed that pre-ESC lines 20, 22, 28 and
33 expressed the OCT4, SOX2 and NANOG pluripotency markers, albeit
at lower levels than those expressed by LYON-ES1 cells (Fig. 4B).
Some pre-ESC lines also expressed the early lineage markers associated
with primed pluripotency, such as T-BRA, FGF5 and SOX17 (Joo et al.,
2014; Chen et al., 2015) (Fig. 4B), at a much higher level than genuine
ESCs. Similar to LYON-ES1 cells, the pre-ESC lines did not express the
late differentiation markers SOX1, AFP, HNF-3β or α-MHC (Fig. 4C).
These results suggest that the pre-ESC lines displayed features of pri-
mate ESCs, but were engaged into early differentiation. After a 7-day
culture in the absence of feeder cells, the morphology of the pre-ESC
lines became heterogeneous and OCT4 and NANOG expression de-
creased (Supplementary Fig. 3A and B), indicating differentiation. Pre-
ESC lines 31–33 produced small-size EBs in suspension culture and
displayed low growth rates, as judged by limited increases in EB size
after 2 weeks in vitro (Fig. 4D). In contrast, LYON-ES1 cells produced
fully developed EBs after 4 days of culture with the rapid expansion of
size over time (Fig. 4D). Moreover, differentiation markers for the
three germ lineages were expressed (Wianny et al., 2008). In addition,
the pre-ESC lines (nb. 31, 32) failed to produce teratomas after
14 weeks when injected into the testis of immunocompromised mice.
In contrast, LYON-ES1 cells injected under the same conditions pro-
duced teratomas after 5 weeks (Fig. 4E).
Thus, the pre-ESC lines can be deﬁned as embryo-derived cell lines
that failed to expand beyondpassage 20. They displayed an impaired ca-
pacity to self-renew and to differentiate in vitro and in vivo.
Next, we investigated methylation status of the SNRPN and H19
DMRs in several pre-ESC lines. The SNRPN DMR analysed among the
ﬁve pre-ESC lines was weakly methylated on the paternal allele
(0.8–18%) but highly methylated on the maternal allele (74–93%),
which was similar to the results observed in LYON-ES1 cells (Fig. 5A).
Thisﬁnding suggests thatmethylation of the SNRPNDMRdoes not differ
between the bona ﬁde and pre-ESC lines. In contrast, the global methyl-
ation rate of theH19/IGF2DMR varied andwas always lower in the pre-
ESC lines (range, 32–61% in the nine lines analysed) than that in the
bona ﬁde ESC lines (73% in LYON-ES1 cells, p b 0.05; 90%, 95% and 96%,
in ORMES-1, ORMES-6 and human H9 ESCs, respectively, p b 0.001)
(Fig. 5B). We took advantage of SNP found in the H19/IGF2 DMR CTCF-
binding site to determine the parental origin of the alleles in four of
the nine pre-ESC lines analysed (nb. 15, 17, 28 and 30; Fig. 5C). In
three of four pre-ESC lines (nb. 17, 28 and 30), the H19/IGF2 DMRmeth-
ylation rate on the maternal alleles was signiﬁcantly lower (mean, 9%)
than that in the bona ﬁde ESC lines at early passage (34%) (Fig. 5C). In
the fourth line (nb. 15), theH19/IGF2DMRmethylation rate on the pater-
nal allelewas signiﬁcantly lower (67%) than that in LYON-ES1 cells (84%).
Taken together, these ﬁndings suggest that the H19/IGF2 DMR methyla-
tion pattern distinguishes bona ﬁde ESC lines from pre-ESC lines.2.3. H19, IGF2 and DNMT3B mRNA levels characterise bona ﬁde primate
ESCs
Methylation of DMRs is typically linked to gene repression. Thus, we
were interested in determining whether the differences observed inFig. 5.Methylation status of the SNRPN andH19/IGF2 differentiallymethylated regions (DM
pre-ESC lines nb. 17, 22 and 31. Each line represents a single allele. Black squares indicate meth
nucleotide polymorphism (SNP) C/G. Right panel, percentagemethylation of the SNRPNDMR in
passage 7.Mean± standard error of themean.B.Globalmethylation rate of theH19/IGF2DMR i
1, ORMES-6 and theH9 human ESC lines. (ANOVA, * p b 0.05, *** p b 0.001).C. Left panel, bisulph
percentage methylation of theH19/IGF2DMR in thematernal and paternal alleles of the pre-ES
test: *, p b 0.05; *** p b 0.001. Different colours associatedwith the numbering of the pre-ESC lin
more than ﬁve passages).H19/IGF2 DMR methylation were associated with altered IGF2 or H19
mRNA expression levels. We found that H19 and IGF2 were expressed
during the early stage of LYON-ES1 cell derivation (passage 3) but the
level of expression sharply decreased at later passages (passages 16
and 43) in LYON-ES1 cells, as observed in other monkey ESC lines
ORMES1, ORMES6 and human ESC lines H1, H9 and HS306 (Fig. 6A).
In contrast, all pre-ESC lines expressed lower levels ofNANOG and failed
to downregulate H19 and IGF2 expression, as indicated by high levels of
expression (Fig. 6A).
We next assessed the expression of DNA methyltransferases
(DNMT)1, 3A and 3B, which are responsible for the establishment and
maintenance of embryonic methylation patterns (Okano et al., 1999;
Watanabe et al., 2002). DNMT1, DNMT3A and DNMT3Bwere expressed
at early stages of LYON-ES1 derivation and remained highly expressed
in LYON-ES1 cells and in all primate ESCs analysed (ORMES-1,
ORMES-6, H1, H9 and HS306 cells) as previously shown (Tang et al.,
2010; Sperger et al., 2003; Adewumi et al., 2007; Nissenbaum et al.,
2013; Liao et al., 2015) (Fig. 6A). In contrast, all pre-ESC lines expressing
pluripotency markers (nb. 20, 22, 28, 32 and 33) (Figs. 4A,B and 6A;
Supplementary Table 2) expressed low levels of DNMT3B (Fig. 6B).
Overall, our results suggest that the bona ﬁde ESC lines can be distin-
guished frompre-ESCs, by low expression levels ofH19 and IGF2mRNAs
and elevated expression level ofDNMT3BmRNA.Most notably, bona ﬁde
ESCs exhibit a high degree of H19/IGF2 DMRmethylation, characterised
by abnormal methylation on the maternal allele (mean, 28%). This spe-
ciﬁcmethylation patternwasmaintained in the ESC lines from the early
stages of derivation to late passages and after differentiation.3. Discussion
The early steps of deriving ESCs are crucial, as the cells are easily af-
fected by changes in culture conditions and in vitromanipulation,which
may alter the methylation status of the sensitive imprinted genes. We
found that the SNRPN and H19/IGF2 DMR methylation patterns ob-
served at the early stages of monkey ESC line derivation did not vary
after long-term expansion or differentiation in vitro. We showed that
the LYON-ES1 cell line, exhibited an alteredH19/IGF2DMRmethylation
pattern (high global methylation rate, with unusual methylation at ma-
ternal alleles), as described previously in other primate ESC lines
(Mitalipov et al., 2007; Nazor et al., 2012). It is unknown whether this
aberrantmethylation pattern emerged in the oocyte during gametogen-
esis, following hormonal stimulation, or during embryonic develop-
ment in vitro. We previously reported alterations in the H19/IGF2 DMR
methylation pattern in human oocytes following ART (Al-Khtib et al.,
2011) and in human embryos produced by ICSI (Ibala-Romdhane
et al., 2011; Khoueiry et al., 2013). A previous study reported that H19
and IGF2 are normally imprinted in ICSI produced monkey blastocysts
produced by ICSI (Fujimoto et al., 2006). However, that study focused
on the allele-speciﬁc H19/IGF2 expression pattern and did not address
per se the H19/IFG2 DMRmethylation status in embryos. There may be
some discordance between DMR methylation and allelic expression in
monkey embryos, as shown in human ESCs (Frost et al., 2011; Kim
et al., 2007a; Grybek et al., 2014; Rugg-Gunn et al., 2005).
We found that the global methylation rate of theH19/IGF2DMR var-
ied but was signiﬁcantly lower in pre-ESCs than that in bona ﬁde pri-
mate ESC lines. We hypothesised that differentiation began rapidly
after plating the ICMs on feeder cells in some of pre-ESC linesRs) in the pre-ESC linesA. Left panel, bisulphite-sequencing analysis of the SNRPNDMR in
ylated CpGs. White squares represent unmethylated CpGs. Red square indicates the single
maternal and paternal alleles of the pre-ESC lines, comparedwith that in LYON-ES1 cells at
n thepre-ESC lines. Each pre-ESC linewas compared to LYON-ES1 cell (passage 7), ORMES-
ite-sequencing analysis of theH19/IGF2DMR inpre-ESC lines nb. 15, 17 and28; right panel,
C lines and LYON-ES1 cells at passage 7. Mean± standard error of themean. Fisher's exact
es indicate themaximumpassage reached by the line (blue, less than ﬁve passages; brown,
Fig. 6. H19, IGF2, DNMT1, DNMT3A and DNMT3BmRNA expression levels in the genuine bona ﬁde ESC lines and pre-ESC lines (A) NANOG, IGF2 and H19mRNA expression levels, and
(B) DNMT1, DNMT3A and DNMT3BmRNA expression levels measured by qPCR in the monkey ESC lines: LYON-ES1 cells (passages 3, 16 and 43), LYON-ES1 cell-derived EBs (7 days),
ORMES-1 cells (passage 16), ORMES-6 cells (passage 20); in the human ESC lines (H1; H9 and HS306); and in pre-ESC lines 20, 22, 28, 32, 33.
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deed, we showed that the pre-ESC lines did not exhibit all features of a
bona ﬁde ESC line. However, molecular characterisation of the pre-ESCs
suggested that they retained some ESC features and that they contained
cells only recently engaged in differentiation. More importantly, we
showed that the H19/IGF2 DMR methylation pattern remained stable
after differentiation of LYON-ES1 cells into EBs and neural precursors.
These results agree with previous studies reporting that epigenetic
marks are stably inherited in differentiating human ESCs (Sun et al.,
2006; Allegrucci et al., 2007). This ﬁnding supports the hypothesis
that the H19/IGF2 DMR methylation pattern observed in pre-ESCs
(low methylation rate on maternal and/or paternal alleles) compared
to that in the bona ﬁde ESC lines and their differentiated derivatives
was not merely a consequence of cell differentiation but rather due to
the lack of acquiring or maintaining ESC properties.
In addition, our results also show that the expression level of IGF2
and H19 mRNA decreased during ESC isolation, from early to late
passages of ESCs, in agreement with published human and mouse
data (Sun et al., 2006; Humpherys et al., 2001; Rugg-Gunn et al., 2007;
Mai et al., 2011; Sun et al., 2012). In contrast, the methylation rate of
H19/IGF2DMR remained stable from early to late passages, highlighting
discordance between methylation status and expression levels of H19
and IGF2 during derivation of monkey ESC lines. This observation maybe surprising because H19/IGF2 DMR is methylated on the paternal al-
lele inmonkey ESCs, and this is generally associatedwith the expression
of IGF2 and reciprocal silencing ofH19. Somediscordance between DMR
methylation and allelic expression has previously been shown inmouse
and human ESCs (Sun et al., 2012; Kim et al., 2007b). ESC lines are iso-
lated from early embryos at a stage of intense epigenetic remodelling,
and embryonic cells must quickly adapt to the in vitro culture
environment. Modulation of the methylation rate at others sites than
H19/IGF2 DMR, as well as other epigenetic mechanisms such as histone
modiﬁcations, may be involved in the modulation of expression of H19
and IGF2 during these processes. Furthermore, in the preimplantation
stage mouse embryo, expression of H19 and IGF2 is restricted to cells
destined to colonise trophectoderm derivatives (Lee et al., 1990;
Negron-Perez et al., 2013). Thus, we hypothesise that a fraction of
differentiated cells that express high levels of H19 and IGF2 mRNAs
are present during the early stages of ESC line derivation, and progres-
sively lost after ESC selection and expansion.
In contrast to bona ﬁde ESC lines, the pre-ESC lines expressed H19
and IGF2mRNAs and lower levels of DNMT3B. Thismay reﬂect their lim-
ited ability to differentiate into the three germ layers, as a high H19 ex-
pression level has been associated with altered differentiation potential
in parthenogenetic ESCs (Ragina et al., 2012), and DNMT3B confers the
capacity to form teratomas (Chen et al., 2003). This also suggests that
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epigenetic mechanisms involved in initiating self-renewal were not
properly established or maintained in these cell lines.
Importantly, the high degree of methylation of the H19/IGF2 DMR
was not detrimental for maintaining pluripotent status of the monkey
ESCs. Indeed, monkey ESC lines that exhibit such an ‘altered’ methyla-
tion proﬁle are fully pluripotent (Fujimoto et al., 2006; Mitalipov et al.,
2007) and show a normal karyotype after long-term culture (Wianny
et al., 2008; Thomson et al., 1998; Mitalipov et al., 2006). Thus, rather
than being considered as a deleterious criterion for the safety of ESC
use in clinical research, a high degree of H19/IGF2 DMR methylation
might be a common signature of pluripotency in primates. An analysis
of other paternally imprinted DMRs, such as the IG-DMR associated
with pluripotency inmouse ESCs (Stadtfeld et al., 2010)will be required
to determine whether this signature is restricted to the H19/IGF2 locus.
We propose that the H19/IGF2 DMR methylation pattern and the
expression levels of H19, IGF2, and DNMT3B mRNA could be used in
conjunction with other well-known pluripotent markers to predict the
outcome of ESC line isolation in monkeys.
4. Material and methods
4.1. Rhesus monkey embryo production using ICSI
Refer to our previous study for details about the embryo production
and culture procedures (Wianny et al., 2008). All experimentswere per-
formed in compliance with national and European laws as well as with
institutional guidelines concerning animal experimentation. Surgical
procedureswere performed in accordancewith European requirements
2010/63/UE. All experimental procedureswere designedwith reference
to the recommendations of the Weatherall report entitled ‘The use of
non-humanprimates in research.’ Laboratory authorisationwas provid-
ed by the ‘Préfet de la Région Rhône-Alpes’ and the ‘Directeur
départemental de la protection des populations’ under permit no:
#A690290402.
4.2. Isolation and culture of the embryonic cell lines
Methods for deriving embryonic cell lines from rhesus monkey em-
bryos produced by ICSI have been described previously (Wianny et al.,
2008). In brief, zonae pellucidae of pre-implantation stage embryos
(16 cell/morula or blastocysts) were removed after brief exposure
(45–60 s) to 0.5% pronase. Expanded blastocysts with distinct ICMs
were subjected to immunosurgery. Isolated ICMs or whole embryos
were plated onto Nunc 4-well dishes containing a feeder layer of
mitomycin-C treated mouse embryonic ﬁbroblasts (MEFs). Two culture
media were used during the early stages of derivation (Supplementary
Table 1): (1) knockout (KO)-DMEMmedium containing 20% foetal bo-
vine serum (FBS) supplemented with 1% non-essential amino acids
(Invitrogen, Carlsbad, CA, USA), 2 mM L-glutamine (Invitrogen) and
0.1 mM β-mercaptoethanol and (2) KO-DMEM medium containing
10% FBS/10% Knockout SerumReplacement (KOSR; Invitrogen), supple-
mented with 4 ng/ml basic ﬁbroblast growth factor (bFGF; Millipore
Corp. Billerica,MA, USA), 1000 IU/ml human recombinant leukaemia in-
hibitory factor, 1% non-essential amino acids, 2 mM L-glutamine and
0.1mM β-mercaptoethanol. ICMs or embryos that attached to the feed-
er layer and initiated outgrowth were dissociated manually into small
cell clumps and re-plated on newMEFs. Emerging colonies were select-
ed for further propagation, characterisation, epigenetic analysis and
freezing. During the early stage of derivation, half of the medium was
changed every other day. Passageswere performedmanually by cutting
the colonies in big clumps using a ﬂame-pulled Pasteur pipette. The col-
onies were re-plated on dishes with fresh feeder layers. Cultures were
maintained at 37 °C in 5% CO2. KO-DMEM medium containing 20%
KOSR, supplemented with 4 ng/ml bFGF, 1% non-essential amino
acids, 2 mM L-glutamine and 0.1 mM β-mercaptoethanol was used tomaintain and amplify themonkey and human ESCs. EBs and neural pre-
cursors were obtained as described previously (Wianny et al., 2008).
4.3. Teratoma formation
Colonies of embryonic cells were inoculated beneath the testicular
capsules of 7 week old severe combined immunodeﬁcient (SCID) male
mice (CB17/SCID; Charles River Laboratories, Shanghai, China; http://
www.criver.com). The mice were euthanised, and the lesions were re-
moved surgically 5–15weeks later (LYON-ES1 cells and pre-ESC lines, re-
spectively). Teratomas were ﬁxed in 4% PFA overnight at 4 °C, incubated
in 10% sucrose for 24 h, in 20% sucrose for 24 h and embedded in OCT em-
bedding medium (CellPath, Newtown, UK; http://www.cellpath.co.uk).
Cryosections (20 μm) were washed three times for 10 min in Tris-
buffered saline (TBS) and processed for immunoﬂuorescence staining
(see (Wianny et al., 2008) for full analysis of teratomas).
4.4. Immunoﬂuorescence
Cells were ﬁxed in 2% PFA in phosphate-buffered saline (PBS) at 4 °C
for 1 h and permeabilized in TBS + 0.1% Triton X-100 (three times for
10 min each). Non-speciﬁc binding was blocked with 10% normal goat
serumor normal donkey serum (Jackson Immunoresearch Laboratories,
West Grove, PA, USA; http://www.jacksonimuno.com) for 20 min at
room temperature (RT). Cells were incubated overnight at 4 °Cwith pri-
mary antibodies (monoclonal anti-SSEA4; 1:100; MAB4304; monoclo-
nal anti-TRA-1-60; MAB4360, 1:100; monoclonal anti-TRA-1-81,
MAB4381, 1:100 Chemicon, Temecula, CA, USA: http://www.
chemicon.com) diluted in diluent (Dako, Glostrup, Denmark; http://
www.dako.fr). After three rinses in TBS, the cells were exposed to either
afﬁnity-puriﬁed goat or donkey anti-mouse, anti-rat, anti-rabbit or anti-
goat immunoglobulin G or M conjugated either to Alexa488, 555 or 647
(Invitrogen) for 1 h at RT. Nuclei were counterstained with 1 mM 4′, 6-
diamidino-2-phenylindole for 3 min. Coverslips were mounted on the
slides after three rinses in TBS. The slides were examined by confocal
microscopy under UV light to detect isothiocyanate (450–490 nm ﬁl-
ter), indocarbocyanine 3 (550–570 nm ﬁlter) and Hoechst 33258 ﬂuo-
rescence (355–425 nm ﬁlter).
4.5. Semi-quantitative reverse transcription-polymerase chain reaction
(RT-PCR)
Total RNAwas prepared with a Qiagen RNeasy kit (Qiagen, Valencia,
CA, USA; http://www.qiagen.com). Standard reverse transcription reac-
tionswere performedwith 1 μg total RNA primedwith random primers
using the RevertAidH minus First strand cDNA synthesis kit (Bioﬁdal,
Vaulx En Velin, France; http://www.bioﬁdal.fr). PCR was conducted
with the PCR Master Mix (New England Biolabs, Ipswich, MA, USA;
http://www.neb.com) using the following parameters: denaturation
at 95 °C for 30 s, annealing at a suitable annealing temperature for
30 s and polymerisation at 72 °C for 30 s. The primer sequences and
the number of cycles used are listed in Supplementary Table 3. An ex-
tension step of 7 min at 72 °C was added at the end of the cycles. Each
PCR was performed under linear conditions. Reactions without reverse
transcriptase were performed to control for genomic DNA contamina-
tion, using β-actin primers. PCR products were analysed on a 1.5% aga-
rose gel and visualised with ethidium bromide.
4.6. Real-time qPCR
RNAwas extracted using RNAeasy kits and on-column DNAse diges-
tion. Reverse transcription was carried out with MuMLV-RT (Promega,
Madison, WI, USA; http://www.promega.com), according to the
manufacturer's recommendations. The primer sequences are listed in
Supplementary Table 3. Quantitative PCR was performed using the
qPCR system and Fast SYBR Green I Master Mix (Applied Biosystems,
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normalisations were carried out using PGK1.4.7. DNA methylation analysis
The methylation proﬁles of the H19/IGF2 DMR and the SNRPN DMR
were determined by bisulphite mutagenesis and sequencing, as
described previously (Lefevre and Blachere, 2015). DNA was extracted
with the Nucleospin® Tissue kit for tissues (Macherey-Nalgel, Hoerdt,
France). The EpiTect® Plus DNA Bisulﬁte Kit (Qiagen) was used accord-
ing to the manufacturer's recommendations. The cells were directly in-
cubated in the kit lysis buffer prior to bisulphite treatment. The
bisulphite conversion rate was N96% (Supplementary Table 4).
Bisulphite-modiﬁed DNA was subjected to duplex-nested PCR.
Twenty-ﬁve (paternal alleles) or 26 (maternal alleles) CpG sites of
the LYON-ES1, ORMES-1 and ORMES-6 monkey ESC lines in a 324 bp
fragment of the SNRPN DMR (126678–127001, NC_007864.1)
harbouring a G/C SNP at nucleotide 126776 for LYON-ES1 or G/C and
A/G at positions 126776 and 126951, respectively, for ORMES-1 or G/T
at nucleotide 126954 for ORMES-6 and 25 CpG in a 427 bp fragment
of H19/IGF2 DMR (222-649; AY725988.1) harbouring a SNP T/A at nu-
cleotide 252 for LYON-ES1 cells (Fig. 3A and D), or three SNPs A/G, G/
A and A/G at positions 331, 335 and 336, respectively, for ORMES-1 or
three SNPs CG/TA and CG at positions 417, 418 and 429, respectively,
for ORMES-6.
For human ESC line H9, we analysed 21 CpG sites in a 326 bp frag-
ment of H19/IGF2 DMR (7771-8096; AF125183) harbouring a SNP T/A
at nucleotide 8008. The following primers speciﬁc for bisulphite-
converted DNA, and speciﬁc to the monkey and human sequences,
were used:
monkey SNRPN,
external forward: 5′-GGTATGTTTATTGATTTTAGGTTGTTTATGG-3′
external reverse: 5′-AAATATCTAATAAATAAAAATAACTACTCCCC
AAA-3′
internal forward: 5′-GTAATAATGTTGTGGGGTTTTAGGG-3′
internal reverse: 5′-CTAATAAATAAAAATAACTACTCCCCAAACTATC
TC-3′;
monkey H19/IGF2,
external forward: 5′-GGTYGTGAGGGATAGGATATTTAT-3′
external reverse: 5′-AATATAACCCCACCTAAAAACCTAATAC-3′
internal forward: 5′-GGTYGTGAGGGATAGGATATTTAT-3′
internal reverse: 5′-CCCATAAATATCCTATTCCCAAAT-3′;
human H19/IGF2,
external forward: 5′-AATAATGAGGTGTTTTAGTTTTATGGATG-3′
external reverse: 5′-ACTTAAATCCCAAACCATAACACTAAAAC-3′
internal forward 5′-AATAATGAGGTGTTTTAGTTTTATGGATG-3′
internal reverse 5′-ATAAATATCCTATTCCCAAATAACCCC 3′
The PCR products were subcloned into the pGEM-T plasmid
(Promega) and 20–40 clones were sequenced for each PCR product
(Bioﬁdal). In contrast to the pyrosequencing analysis, bisulphite se-
quencing combined with SNPs enables precise quantiﬁcation of the
DMRmethylation rate at each allele. Each sequencewas carefully exam-
ined, and identical alleles were counted only once. The presence of un-
certain, modiﬁed or deleted nucleotides (b3%; Supplementary Table 4)
enabled us to discriminate distinct alleles that showed apparently iden-
tical methylation proﬁles. The bisulphite sequencing protocol was vali-
dated using genomic DNA extracted from the blood of the female who
provided the oocytes to derive the LYON-ES1 cells. Mean H19/IGF2
DMR methylation rate was 56 ± 2%, indicating no bias toward methyl-
ated or non-methylated alleles. This DMR was highly methylated
(94.0±0.3%) in sperm, as expected. A statistical analysis ofmethylation
rates was carried out using analysis of variance, and differences were
considered signiﬁcant when p b 0.05. We used Fisher's exact test to de-
termine allele methylation status.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.03.002.
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